PMC:7289100 / 2773-3150 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T9","span":{"begin":223,"end":231},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"involvement including hematological, gastrointestinal, neurological and cardiovascular complications leading to death [[19], [20], [21], [22], [23]]. The ARDS described in up to 20% of Covid-19 cases, is reminiscent of the cytokine release syndrome-induced ARDS and secondary hemophagocytic lymphohistiocytosis (sHLH) observed in patients with SARS-CoV and MERS-CoV as well as "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T39","span":{"begin":154,"end":158},"obj":"Disease"},{"id":"T40","span":{"begin":257,"end":261},"obj":"Disease"},{"id":"T41","span":{"begin":266,"end":310},"obj":"Disease"},{"id":"T42","span":{"begin":276,"end":310},"obj":"Disease"},{"id":"T43","span":{"begin":312,"end":316},"obj":"Disease"},{"id":"T44","span":{"begin":344,"end":352},"obj":"Disease"},{"id":"T45","span":{"begin":344,"end":348},"obj":"Disease"}],"attributes":[{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A41","pred":"mondo_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/MONDO_0015542"},{"id":"A42","pred":"mondo_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/MONDO_0015540"},{"id":"A43","pred":"mondo_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/MONDO_0015542"},{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"involvement including hematological, gastrointestinal, neurological and cardiovascular complications leading to death [[19], [20], [21], [22], [23]]. The ARDS described in up to 20% of Covid-19 cases, is reminiscent of the cytokine release syndrome-induced ARDS and secondary hemophagocytic lymphohistiocytosis (sHLH) observed in patients with SARS-CoV and MERS-CoV as well as "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T33","span":{"begin":138,"end":140},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"}],"text":"involvement including hematological, gastrointestinal, neurological and cardiovascular complications leading to death [[19], [20], [21], [22], [23]]. The ARDS described in up to 20% of Covid-19 cases, is reminiscent of the cytokine release syndrome-induced ARDS and secondary hemophagocytic lymphohistiocytosis (sHLH) observed in patients with SARS-CoV and MERS-CoV as well as "}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T26","span":{"begin":223,"end":248},"obj":"Phenotype"}],"attributes":[{"id":"A26","pred":"hp_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"involvement including hematological, gastrointestinal, neurological and cardiovascular complications leading to death [[19], [20], [21], [22], [23]]. The ARDS described in up to 20% of Covid-19 cases, is reminiscent of the cytokine release syndrome-induced ARDS and secondary hemophagocytic lymphohistiocytosis (sHLH) observed in patients with SARS-CoV and MERS-CoV as well as "}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T53","span":{"begin":37,"end":53},"obj":"UBERON:0005409"},{"id":"T54","span":{"begin":55,"end":67},"obj":"UBERON:0001016"},{"id":"T55","span":{"begin":72,"end":86},"obj":"UBERON:0004535"},{"id":"T56","span":{"begin":112,"end":117},"obj":"GO:0016265"},{"id":"T57","span":{"begin":185,"end":193},"obj":"SP_7"},{"id":"T58","span":{"begin":223,"end":231},"obj":"GO:0019221"},{"id":"T59","span":{"begin":276,"end":290},"obj":"GO:0030097"},{"id":"T60","span":{"begin":344,"end":352},"obj":"SP_10"},{"id":"T61","span":{"begin":357,"end":365},"obj":"SP_9"},{"id":"T31865","span":{"begin":37,"end":53},"obj":"UBERON:0005409"},{"id":"T23836","span":{"begin":55,"end":67},"obj":"UBERON:0001016"},{"id":"T51010","span":{"begin":72,"end":86},"obj":"UBERON:0004535"},{"id":"T74903","span":{"begin":112,"end":117},"obj":"GO:0016265"},{"id":"T43778","span":{"begin":185,"end":193},"obj":"SP_7"},{"id":"T76985","span":{"begin":223,"end":231},"obj":"GO:0019221"},{"id":"T80671","span":{"begin":276,"end":290},"obj":"GO:0030097"},{"id":"T49512","span":{"begin":344,"end":352},"obj":"SP_10"},{"id":"T61627","span":{"begin":357,"end":365},"obj":"SP_9"}],"text":"involvement including hematological, gastrointestinal, neurological and cardiovascular complications leading to death [[19], [20], [21], [22], [23]]. The ARDS described in up to 20% of Covid-19 cases, is reminiscent of the cytokine release syndrome-induced ARDS and secondary hemophagocytic lymphohistiocytosis (sHLH) observed in patients with SARS-CoV and MERS-CoV as well as "}

{"project":"LitCovid-PubTator","denotations":[{"id":"82","span":{"begin":330,"end":338},"obj":"Species"},{"id":"83","span":{"begin":344,"end":352},"obj":"Species"},{"id":"84","span":{"begin":357,"end":365},"obj":"Species"},{"id":"100","span":{"begin":72,"end":100},"obj":"Disease"},{"id":"101","span":{"begin":112,"end":117},"obj":"Disease"},{"id":"102","span":{"begin":154,"end":158},"obj":"Disease"},{"id":"103","span":{"begin":185,"end":193},"obj":"Disease"},{"id":"104","span":{"begin":257,"end":261},"obj":"Disease"},{"id":"105","span":{"begin":266,"end":310},"obj":"Disease"}],"attributes":[{"id":"A82","pred":"tao:has_database_id","subj":"82","obj":"Tax:9606"},{"id":"A83","pred":"tao:has_database_id","subj":"83","obj":"Tax:694009"},{"id":"A84","pred":"tao:has_database_id","subj":"84","obj":"Tax:1335626"},{"id":"A100","pred":"tao:has_database_id","subj":"100","obj":"MESH:D002318"},{"id":"A101","pred":"tao:has_database_id","subj":"101","obj":"MESH:D003643"},{"id":"A102","pred":"tao:has_database_id","subj":"102","obj":"MESH:D012128"},{"id":"A103","pred":"tao:has_database_id","subj":"103","obj":"MESH:C000657245"},{"id":"A104","pred":"tao:has_database_id","subj":"104","obj":"MESH:D012128"},{"id":"A105","pred":"tao:has_database_id","subj":"105","obj":"MESH:D051359"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"involvement including hematological, gastrointestinal, neurological and cardiovascular complications leading to death [[19], [20], [21], [22], [23]]. The ARDS described in up to 20% of Covid-19 cases, is reminiscent of the cytokine release syndrome-induced ARDS and secondary hemophagocytic lymphohistiocytosis (sHLH) observed in patients with SARS-CoV and MERS-CoV as well as "}

{"project":"2_test","denotations":[{"id":"32535093-32109013-4828854","span":{"begin":120,"end":122},"obj":"32109013"},{"id":"32535093-18300583-4828855","span":{"begin":132,"end":134},"obj":"18300583"},{"id":"32535093-32307952-4828856","span":{"begin":138,"end":140},"obj":"32307952"}],"text":"involvement including hematological, gastrointestinal, neurological and cardiovascular complications leading to death [[19], [20], [21], [22], [23]]. The ARDS described in up to 20% of Covid-19 cases, is reminiscent of the cytokine release syndrome-induced ARDS and secondary hemophagocytic lymphohistiocytosis (sHLH) observed in patients with SARS-CoV and MERS-CoV as well as "}